Pages that link to "Q39010730"
Jump to navigation
Jump to search
The following pages link to A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection (Q39010730):
Displaying 30 items.
- The Phosphatidylserine and Phosphatidylethanolamine Receptor CD300a Binds Dengue Virus and Enhances Infection (Q24672470) (← links)
- Mast Cell Clonal Disorders: Classification, Diagnosis and Management (Q28070386) (← links)
- Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcome (Q33168552) (← links)
- Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models. (Q38635953) (← links)
- Histone deacetylase inhibitor SAHA mediates mast cell death and epigenetic silencing of constitutively active D816V KIT in systemic mastocytosis (Q37706037) (← links)
- Current treatment options in patients with mastocytosis: status in 2015 and future perspectives (Q38370943) (← links)
- Use of humanized rat basophilic leukemia reporter cell lines as a diagnostic tool for detection of allergen-specific IgE in allergic patients: time for a reappraisal? (Q38603233) (← links)
- A new humanized in vivo model of KIT D816V advanced systemic mastocytosis monitored using a secreted luciferase. (Q38736625) (← links)
- Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia (Q38866094) (← links)
- Neuroendocrinology of mast cells: Challenges and controversies (Q39091869) (← links)
- Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. (Q39189663) (← links)
- A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis. (Q39383946) (← links)
- Midostaurin: a magic bullet that blocks mast cell expansion and activation (Q47930863) (← links)
- Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells. (Q48104415) (← links)
- The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis. (Q50035104) (← links)
- Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo (Q51068291) (← links)
- CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis. (Q51322003) (← links)
- ROSA KIT WT (Q54950835) (← links)
- ROSA KIT D816V (Q54950836) (← links)
- Preclinical human models and emerging therapeutics for advanced systemic mastocytosis (Q59810100) (← links)
- Japanese encephalitis virus neuropenetrance is driven by mast cell chymase (Q61796951) (← links)
- In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis (Q64103896) (← links)
- Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells (Q89449227) (← links)
- CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis (Q90292270) (← links)
- Platelets trigger perivascular mast cell degranulation to cause inflammatory responses and tissue injury (Q90613314) (← links)
- Divergent Effects of Acute and Prolonged Interleukin 33 Exposure on Mast Cell IgE-Mediated Functions (Q91638939) (← links)
- Immunomodulatory role of Interleukin-33 in large vessel vasculitis (Q91892681) (← links)
- Identification of a leukemia-initiating stem cell in human mast cell leukemia (Q92887046) (← links)
- Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis (Q93037900) (← links)
- Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts (Q99419174) (← links)